Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-91 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 |
filingDate |
2018-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2019143639-A |
titleOfInvention |
BOTULINIC NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH OVERACTIVE MELANOCYTES AND / OR EXCESS MELANIN |
priorityDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |